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Henry J. Amoroso, J.D., president and

chief executive officer of Saint Vincent
Catholic Medical Centers.
Regina M. Giuffrida, M.D. ’80, a partner
at the Mount Kisco Medical Group, a multispecialty physician group in Westchester
County, N.Y.
Jane Haher, M.D. ’67, associate profes-

sor of surgery and chief of plastic, reconstructive and hand surgery at St. Vincent’s
Hospital Manhattan.
– Photo by Photobureau, Inc. –

ew York Medical College awarded 183
doctor of medicine (M.D.) degrees, 16
doctor of physical therapy (D.P.T.) degrees,
9 doctor of philosophy (Ph.D.) degrees, 45
master of science (M.S.) degrees and 85
master of public health (M.P.H.) degrees at
the 148th Commencement exercises held
on May 24 in Carnegie Hall. Jo Ivey
Boufford, M.D., president of the New York
Academy of Medicine, delivered the
Commencement address to the Class of
2007, invoking them to make the world a
healthier place with their leadership and
commitment.

N

Julie A. Kubaska, M.S., has been
appointed vice president of development
and alumni relations. She joined the
College in 1989 as director of alumni relations. Her new responsibilities involve overseeing the functions of the Office of
Development, which include planned giving,
major gifts, annual giving, corporate and
foundation relations, advancement services
and development communications and publications. Ms. Kubaska holds B.A. and M.S.
degrees from The College of New Rochelle.

Michael D. Israel, M.P.H., president and
chief executive officer of Westchester
Medical Center.
Eugene C. Rainis, M.B.A., a limited

partner of Brown Brothers Harriman & Co.,
a wholly owned and managed private
banking, securities brokerage and financial
advisory firm.
Gerard D. Robilotti, M.S., principal of

Robilotti Consulting, LLC, in Newtown, Conn.
William E. Whiston, M.B.A., chief financial officer for the Archdiocese of New York.

Two new department chairmen have been
appointed: Howard Blanchette, M.D., as
chairman of the Department of Obstetrics
and Gynecology, and Thomas H. Hintze,
Ph.D. ’80, chairman of the Department of
Physiology. Dr. Blanchette succeeds Sari
Kaminsky, M.D., professor of clinical obstetrics and gynecology, who served as acting
chair since 2006. Dr. Hintze became chair
after it was announced that Gabor Kaley,
Ph.D., was leaving the post, although he
will remain on the faculty. Dr. Kaley held the
distinction of being the longest sitting chairman of physiology in the nation.
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Ira Schwartz, Ph.D.,
Turning 60,
KNOWS THE BEST IS YET TO COME
The chairman of microbiology and immunology can hardly wait for his
eight young grandsons to grow up. Meanwhile, the deeply religious scientist,
an ordained rabbi, researches Lyme disease and provides the
“best possible environment” for his department faculty to succeed.
By Marjorie Roberts

N

orman Rockwell never met Ira
Schwartz, Ph.D. If he had, a likeness of Dr. Schwartz surely would
have graced the cover of a Saturday
Evening Post. Rockwell was a master at
capturing the essence of the human race by
showing how ordinary men lived their
lives—ordinary as in typical, not run-of-themill. Everyman scientist Ira Schwartz, professor and chairman of the Department of
Microbiology and Immunology at New York
Medical College, surely fits the bill.
It is five years since Provost and Dean
Ralph A. O’Connell, M.D., appointed him to
the position, which remained unfilled even
after a lengthy search that followed the
departure of the previous chairman,
Soldano Ferrone, Ph.D. Dr. Schwartz was a
member of that search committee when
several members of the department asked
him to put his name in for the job, and so
he did. But it was not a simple decision,
because he’d been through it once before.
In 1997, when he was interim chairman of
the Department of Biochemistry and
Molecular Biology, he was a candidate to
succeed the late Isidore Danishefsky, Ph.D.,
and was not chosen. To be vulnerable
again, to say nothing of taking on such a
formidable job, seemed a small price to
4
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pay for what he knew he could accomplish,
so Ira Schwartz did the right thing.
“They made the right choice when they
hired Dr. [Ernest Y.C.] Lee,” Dr. Schwartz
says of the former University of Miami scientist who was recruited as biochemistry
chair. “When I put my name in for the
microbiology chair, it’s not as if I wasn’t perfectly happy doing what I was doing. I had
an active, very productive biochemistry lab
with four senior level Ph.D.s who were
working at the highest level, and they all
told me to go for it. But what finally turned
the switch on in my head was a conversation with my wife, who is a lot smarter than
I am. ‘Is being chairman of a department
what you ultimately want? If you don’t do
this…’ She didn’t have to finish the sentence.
I realized I did have the desire to build
something of value and this presented a
great opportunity—to show what a department of microbiology and immunology
should look like.”

New blood
There was a faculty of seven, mostly immunologists, when he took over. Now there are
11 on board the tenure track. Dr. Schwartz
occupies the same chairman’s office, “only
with new furniture, which I was told I had to

get. I actually was embarrassed by the size
of the office and I wanted to cut it in half,”
says the department head who seems to
have buried the ego that often comes with
the territory.
He prefers to be in his lab with four Ph.D.s,
two doctoral candidates and enough feng
shui to accommodate his current grants.
Two are from the NIH, “Determinants of
B. burgdorferi Hematogenous Dissemination”
and “Genotypic Variation and B. burgdorferi
Pathogenesis,” with Gary P. Wormser, M.D.,
co-P.I., and one from the CDC, “Lyme
Disease Diagnosis with Host Gene
Expression Arrays,” for a current year total
of $657,000.
Dr. Wormser, professor of medicine and
vice chairman of the Department of
Medicine at the College and Chief of
Infectious Diseases at Westchester Medical
Center, appreciates what Dr. Schwartz has
brought to the collaboration:
“Ira is far and away the best collaborator
with whom I have had the pleasure to
work. He has the rare ability to interrelate
basic and clinical sciences, in no small
measure due to his uncanny ability both to
understand clinical issues and to communicate complex basic science concepts

A chemistry set given to him as a boy may have been the inspiration for Ira Schwartz, Ph.D.’s stellar career in medical science, first in biochemistry and
molecular biology, and since 2002, as chairman of the Department of Microbiology and Immunology. Members of his laboratory who are delving into
the complexities of Lyme disease are, from left, Ph.D. candidate Priyanka Ganguli; Dionysios Liveris, Ph.D., research assistant professor; Dr. Schwartz;
Ph.D. candidate Christopher Pappas, M.S.’06; Radha Iyer, Ph.D., research associate; and Mary Petzke, Ph.D., research associate. Not shown are Klara
Hanincova, Ph.D., post-doctoral fellow, and Ph.D. candidate Darya Terekhova.

effectively to clinicians…And he’s a real
mensch.” [translated from the Yiddish, “a
stand-up guy.”]

Targeting ticks
New York Medical College found a subject
of interest in Lyme disease, no doubt
stoked by its location in Valhalla, on the
leading edge of Northern Westchester, an
endemic area for the tick-borne infection. In
1990, New York State awarded the College
its first grant to support research in Lyme,
which at the same time it was being over
diagnosed, was paradoxically being under
diagnosed. Indeed, it was the suspicion of
Lyme disease that led Dr. Schwartz to study
the infection in the first place.
“In February that year, my wife and I went hiking at Bear Mountain. Two days later she
found an angry-looking bite on the back of
her thigh. I told her to check it out in the hospital where she was working. The doctor there
said he’d do a Lyme test. Now, I had never
heard of Lyme disease. Of course it was negative—it was out of season and probably a
spider bite. I went to the library and found out

the test was not reliable. Eventually I developed a nucleic acid test with internal funding
from the state. Meanwhile, I had met Gary
[Wormser] and Durland Fish [Ph.D., a former
College faculty member now at Yale], and
within two years I had an NIH grant that is
now in its sixteenth year of funding. The
research focus has evolved and the grant title
has changed,” he says.
The testing and treatment of Lyme disease
are still controversial. It is difficult to diagnose because the agent of transmission, the
B. burgdorferi spirochete, is present in
blood only in very low numbers. Patients
with lingering symptoms tend to demand
continued use of antibiotics, a practice that
Schwartz, along with many colleagues,
refutes as usually unwarranted and potentially harmful.
”A blood test that is sensitive and accurate
in detecting the agent of transmission,
the B. burgdorferi spirochete, is difficult to
achieve because the presence of the bacteria in the blood is transient. Besides, there
simply is zero evidence that these chronic

symptoms are due to an active bacterial
infection that can be treated successfully
with antibiotics, so to continue to treat
with antibiotics what some refer to as
chronic Lyme disease is inappropriate and
not doing patients any favor,” he says.
“We have a broad-based research program
at the College that involves genomic and
genetic studies of the bacterium that
causes the disease and also includes the
ecological aspects of Lyme. But it is our
longstanding collaboration with the
Department of Medicine’s Division of
Infectious Diseases and Gary Wormser that
has led to our seminal discovery—the identification of different strains of B. burgdorferi that differ in their pathogenic potential.
A major part of the program is trying to
understand at the genetic level what contributes to these differences, to elucidate
the molecular mechanism of pathogenesis
to predict the probability of a disseminated
infection from a tick bite. We’re also working on a diagnostic test based on gene
(continued on page 20)
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FROM SHANGHAI TO
INNSBRUCK TO VALHALLA...

a scientist follows his bliss
Nephrologists are kidney specialists, but not all physicians are
comfortable treating patients. Wenhui Wang, M.D., has researched the
bean-shaped organ for 30 years.
By Nelly Edmondson Gupta

W

enhui Wang, M.D., professor of
pharmacology and an expert in
renal physiology at New York
Medical College, makes a habit of doing
only things he likes. As luck would have it,
he generally only likes things that are good
for him. For example, he eats whatever he
pleases but prefers fish to meat. He used
to smoke but gave it up because cigarette
breaks interrupted his lab experiments. He
even enjoys his daily half-hour run. And
perhaps most important, he has built a
distinguished career in research because it
pleases him. “I never force myself,” he says
with a grin.

If enlightened self-indulgence helps explain
why the trim 58-year-old looks younger than
his age, so might his spirit of intellectual
adventure. Dr. Wang admits that when he
began unraveling the mysteries of the human
kidney three decades ago, he knew very little
about the bean-shaped organs that lie deep
within the retroperitoneum. “In China I was
doing research related to endocrinology, but
I wanted to move to Austria, and Innsbruck
had an international reputation for kidney
research,” he explains. “It’s not like the United
States, where you can pick any research topic.
That was my only opportunity, so I grabbed it
and afterwards I thought, ‘I like it!’”

The National Institutes of Health likes Dr.
Wang’s work, too. In the past five years, it
has funded him to the tune of close to $1
million annually.
Dr. Wang’s enthusiasm for his chosen field
has taken him a long way, personally and professionally. Recently he talked about his work,
his life, and why the United States is still, in
many ways, the best country in the world.

Studying the
universe within
Dr. Wang’s research takes him to the inner
reaches of the human body, where he focuses

Pictured above: Dr. Wang’s laboratory team includes, from left, research associates Peng Sun, Ph.D., and Peng Yue, M.D., Ph.D., Daohung Lin, M.D., Ph.D.,
research assistant professor, and Zhijian Wang, Ph.D. candidate.
6
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This graphic illustrates the mechanism by which the intake of dietary potassium
(K) regulates the excretion of K from the kidney. The mechanism is essential for
maintaining a normal plasma K concentration under physiological conditions. If
the secretion of K in the kidney fails to match the dietary intake; this leads to
either a high plasma or a low plasma K concentration which can cause a lifethreatening irregular heartbeat. In figure A, when K intake increases, the kidney’s
influence on the level of K excretion occurs through a specific renal cell that
increases the expression of ROMK channels, a K channel responsible for K
secretion in the kidney. The kidney acts similarly to preserve K (figure B) when
there is a decreased dietary intake, the ROMK channels are removed from the cell
membrane in a process known as endocytosis. Used with permission. Physiology
20:140-146, 2005. Fig. 4, Models of high and low K intake in principal cells.

on ion channels—pore-like structures spanning cell membranes in the kidney that help
regulate the blood levels and urinary excretion of sodium and potassium. Describing
his work in layman’s terms, he sounds more
like an astronomer than a pharmacologist.
“It’s like when you find a new star,” he says.

“In science you never can
say I have learned
enough. There is always
something more; your
mind is active; your hands
can do something; you
can work, you can read,
you can think.”
“When you look at ion transport you will
always find unknowns. With new technology
and knowledge from other studies you may
find you’re close to the goal, but you’ll never
totally reach it; there’s always something
new to learn.”
To illustrate his point, Dr. Wang offers a
down-to-earth example: “We know that
potassium channels are regulated by how
much potassium you eat. If you eat two
bananas all the potassium channels on the
cell membrane will open. If you don’t eat
anything with potassium in it, those channels will close down.”
Some of the things we don’t yet know are
“how, exactly, the channels close down; how
molecules are inserted into the channels,
and which factors regulate the trafficking of
the channels.” Human kidneys may look
small, says Dr. Wang, but they are complex
enough to keep a cadre of scientists busy for
the foreseeable future.
Alberto Nasjletti, M.D., professor of pharmacology and director of a longstanding NIH
Program Project Grant for Hormonal Control
of Blood Pressure, has high praise for Dr. Wang,

calling him “charismatic and enthusiastic,”
and no less than “an international star in the
field of ion transport in the kidney.” He goes
on to describe the younger man’s contributions to the department and the College: “Dr.
Wang’s research is highly relevant to the
research activities of many of his colleagues
in the Department of Pharmacology. And
because he is so willing to interact with fellow scientists, Dr. Wang casts a decisive and
positive influence on the academic environment of this institution. He truly commits
himself.”
Currently, Dr. Wang is working on two projects–one looking at potassium channels and
another involving sodium channels. If we
can better understand how these channels
operate, he says, we may be able to create
more effective therapies for hypertension
and other cardiovascular diseases, diabetes,
electrolyte disorders and more.
In the future, predicts Dr. Wang, it may be
possible to take a single blood sample and
from it analyze whatever ion channel glitch
is causing a problem. The end result, he
hopes, will be medications that are more
highly targeted and, because they are not
systemic, produce fewer side-effects than
those currently on the market. He says it
also pays to look at the old drugs for efficacy
and response time.

Proud American
Born in Shanghai, Dr. Wang has lived in
three very different places—China, Europe
and the United States. In 1979, he left his
native land and moved to Innsbruck, where
he earned his M.D. degree. Then he returned
to China. While doing his internship, Dr.
Wang decided clinical work was not for him.
“I tried to work in the hospital, but I didn’t
like it,” he says. “Maybe it’s my personality; I
don’t like doing things rush, rush, rush and
following protocol. I like to think for myself.”
After making the decision to pursue
research, Dr. Wang realized that he couldn’t
remain in China. Inadequate funding left

most labs there virtually empty, and conducting meaningful research was nearly
impossible. At that point, Dr. Wang
went to the University of Wuerzburg in
Germany. He worked for a couple of years
there with a mentor, who helped him land a
job at Yale, where he worked as an associate
research scientist in the department of cellular and molecular physiology. In 1993 he
came to the College, and never left. In 1997,
Dr. Wang became a U.S. citizen. “I like it here,
I feel at home,” he says.
Before coming to the States, Dr. Wang
assumed that America and Western Europe
were similar societies. After spending time
here, however, he realized that Europe was
still relatively closed. “Unless you’re a citizen, they don’t offer opportunities to foreign-educated people,” he says. “I have
friends in Europe, but regardless of how
many years you stay there, you feel you
don’t belong. When you come to the States,
after a couple of years you become part of it.
And here, especially in the universities,
there is no discrimination based on who
you are, where you come from or how old
you are. As long as you can make a meaningful contribution, we don’t exclude anybody. And that is unique.”

Defending the system
Despite recent news stories about the superiority of math and science education in
China and India, Dr. Wang is a fan of the
American educational system. While students elsewhere may do better on standardized tests, he thinks rote learning, which is
still emphasized in Asia, isn’t enough. “Here,
after a person is finished with school they
know how to learn things by themselves;
how to grab knowledge. Here we teach students how to think and improve themselves,
not to simply believe in authority.”
In addition to his research, Dr. Wang teaches
medical students and mentors masters
level and doctoral students. Currently, he is
(continued on page 20)
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For ZOLTAN UNGVARI, M.D., Ph.D.,
Researching Vascular Aging
IS A FAMILY AFFAIR

Inspired and
mentored by
legendary faculty in
the Department of
Physiology, he and
his team (which
happens to include
his wife) are going
after the causes
of inflammation.

Zoltan Ungvari, M.D., Ph.D., foreground, associate professor of physiology, devotes much of his research
to exploring the ways in which high blood pressure inflames susceptible vessels. His team includes,
from left, Anna Csiszar, M.D., Ph.D., assistant professor of physiology, Aracelie Rivera, M.S. ’06, research
technician, and Nazar Labinskyy, M.D., a research fellow.

By Dan Hurley
or Zoltan Ungvari, M.D., Ph.D., unlocking the secrets to vascular inflammation is a family affair. Not only has
the associate professor of physiology coauthored papers on the subject with his wife,
Anna Csiszar, M.D., Ph.D., an assistant professor in the Department of Physiology, but
the elder of their two young children has
recently announced, at the wise old age of
three, that she is going to do what Mommy
does when she grows up.

F

“Perhaps it’s because of our science-related
conversations over dinner. It’s kind of a 24/7
relationship,” he says.
Dare one say it? Vascular inflammation has
set these two physiologists’ hearts afire.

8
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“Inflammation is such a global mechanism of
disease in the body,” Dr. Ungvari says. “Pick a
disease of aging and you will find it is an
inflammatory disease, whether it’s Alzheimer’s,
atherosclerosis or even cancer. I am very happy
that in vascular biology, we are learning to
actually modify this inflammatory process and
see significant outcomes as a result.”
His collaboration with Dr. Csiszar notwithstanding, Dr. Ungvari’s work stands very
much on its own. Having co-authored more
than 60 papers since 1996, he is funded by
the likes of the National Institutes of Health
and the American Heart Association (AHA).
Since last year, he has co-authored six published papers on the vascular benefits of
resveratrol, a compound found in the skin

of berries, grapes and, in small amounts,
wine. He and colleagues have found that it
acts not only as an anti-inflammatory, but
also as an anti-apoptopic and antioxidant
on vessel walls.

He is also grateful for the mentoring of Dr.
Kaley, who sent him in 2003 to attend the
intensive, six-week physiology course held
at the Marine Biological Laboratory (MBL)
in Woods Hole, Mass. Dr. Ungvari has since
become a regular each summer at the MBL,
where he has been researching mechanisms
involved in cellular oxidative stress resistance in successfully aging species.

Hungarian
proving ground
His journey to the forefront of vascular
research began in a resort town on the
shores of Hungary’s Lake Balaton, where he
grew up. Determined to be a biological
researcher from his earliest days, he was
encouraged by his parents, both physicians,
to go to medical school. While pursuing his
medical degree at Semmelweis University of
Medicine in Budapest, he began conducting
research on animal models of hypertension
in pregnancy. It was also where he met his
future wife. Upon graduating summa cum
laude in 1996, he enrolled in the university’s
Ph.D. program in pathophysiology, where he
studied endothelial dysfunction in metabolic
diseases and the cardiovascular side effects
of the antidepressant fluoxetine (Prozac).
“I can fondly recall the excitement of our first
discoveries on the calcium channel
inhibitory properties of fluoxetine, sleeping
on the lab floor for several days and ordering
pizzas for the department,” he says.
While at Semmelweis University he had the
good fortune to meet Akos Koller, M.D., Ph.D.,
now a professor of physiology at the College,
who had also graduated from Semmelweis
and had since conducted groundbreaking
work on the role of blood flow in the regulation of microcirculatory function. “Everyone
in Hungary who was working in the field had
read his papers and learned to use his methods,” Dr. Ungvari says.
Invited by Dr. Koller and then-chair of the
Department of Physiology, Gabor Kaley,
Ph.D., to pursue postdoctoral studies here,
Dr. Ungvari came to the United States in 1999
and made it his home.
“The physiology faculty of New York Medical
College were very well known to me from their
publications,” Dr. Ungvari says. “A whole generation of young European microcirculatory
researchers have used the papers of Dr. Koller,
An Huang [M.D., Ph.D., assistant professor of
physiology], Dong Sun [M.D., Ph.D., associate
professor of physiology] and Edward Messina
[Ph.D., professor of physiology] as essential
methodological ‘cookbooks.’”

Olympian stamina
Like many in Hungary, Dr. Ungvari also knew
that Dr. Koller had another claim to fame: he
had membership on the Hungarian Olympic

“The laboratory mouse is extremely shortlived, living only up to about three years,” he
says, “whereas other animals with similar
body size can live a much longer lifespan.”
Earlier this year, he co-authored a paper on
vascular aging in the longest-living rodent,
the naked mole-rat, which can live more
than 28 years. The study found that the
naked mole-rat maintains a youthful vascular function that protects it against aginginduced oxidative stress.

Dr. Ungvari and his team study long-lived
species to better understand the secrets of
successful vascular aging. Above, aortic
endothelial cells from the white-footed mouse
(Peromyscus leucopus), which lives three times
longer than the house mouse, show marked
resistance against the toxic effects of oxidized
LDL. From top to bottom: cross sections of
untreated and oxLDL-treated house mouse and
white-footed mouse aortas; arrows point to
TUNEL positive apoptotic endothelial cells.
Right panels show nuclear counterstaining in
the same sections. Experiments performed in
collaboration with Praveen Ballabh, M.D.,
associate professor of anatomy and cell
biology. [Csiszar, Ungvari et al, “Vascular
superoxide and hydrogen peroxide production
and oxidative stress resistance in two closely
related rodent species with disparate longevity.”
Aging Cell, October 2007, Blackwell Publishing.]

water polo team in the 1980s. He missed his
chance to earn a medal only because the
Soviet bloc countries boycotted the 1984
games in Los Angeles.
“His friends on the team called him Rocket
because of his stamina, and I can attest that
he earned the name,” Dr. Ungvari says.
“During the time that I was working with
him, I can’t tell you how many papers we
published in a very short period of time.
That was one of the most productive periods
in my life. I learned a lot from him about
stamina and focus, how to bring a project to
the finish line. That’s something I’m very
grateful to him for.”

He devotes much of his research at the
College to discerning the ways in which high
blood pressure inflames susceptible vessels.
“High pressure in the vessel initiates signal
transduction, which begins to produce all
kinds of inflammatory cytokines,” he says.
“But the mechanisms underlying this
process are not completely understood. We
focus on the regulation of these inflammatory cytokines by bone morphogenetic proteins-2/4, which affect vascular calcification
and endothelial activation.”
Pleased to share his scientific interests with
Dr. Csiszar, he says she has brought fresh
ideas regarding the role of inflammatory
cytokines to disease processes. He notes with
pride that his wife was chosen recently to
receive the prestigious Nathan W. Shock
Lecture Award from the National Institute
of Aging.
“I also feel very lucky that in our department
I have other wonderful colleagues who share
my excitement about vascular aging
processes,” Dr. Ungvari says. “I hope that our
fruitful collaborations with Thomas Hintze
[Ph.D., professor and new department chair]
and Michael Wolin [Ph.D., professor of physiology] on age-related alterations in cardiac
function and free radical signaling will last
for years to come.”
Drs. Ungvari and Csiszar are laying the
ground work for their progeny to follow in
their footsteps. In addition to 3-year-old Anna
Sara, there is 11-month-old Julia Rebecca,
who is beginning to mimic what her sister
does. “Anna loves animals, mice, bugs, and
all the sea creatures she found crawling
around in the Marine Biological Laboratory in
Woods Hole,” Dr. Ungvari said. “We have high
hopes for another biologist in the family.”
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PRECEPTOR PROGRAM—
Teaching Students The Art of Medicine
Most medical students arrive at the doorstep of New York Medical College
with a lifelong dream and a powerful drive to begin using their
new doctoring skills. They don’t have long to wait.
By Barbara Burgower Hordern

When Ariadne Avellino, Class
of 2009, first came to New York
Medical College, she didn’t
know exactly what to expect.
She had worked as an emergency medical technician in
high school and college, and
graduated from the University
of Montana-Missoula before
doing clinical research in a
post-baccalaureate program at
the University of Pennsylvania.
In medical school she found
the workload was heavy but
manageable. But it was her
first-year preceptorship that
really inspired her, assuring her
destiny.

ing learning how to work with individuals whose health beliefs or cultures
are different than their own,” explains
Karen Edwards, M.D., M.P.H. ’91,
associate dean for primary care in
the Office of Undergraduate Medical
Education and director of the
Introduction to Primary Care course.

Real patients, real feedback

Like all students in the School of Medicine, Lisa Bienia and Ariadne
Avellino, members of the Class of 2009, made great strides in their
hands-on medical education by working with patients under the
guidance of physician preceptors during their first two years of
medical school—before the clinical years officially begin.

At New York Medical College, all
medical students are matched
with physician preceptors who
give them practical training in a true medical setting. In the first
year, the Introduction to Primary Care course places them in the
offices of primary care physicians, where they learn about doctoring shoulder-to-shoulder with a physician preceptor. Begun nearly
20 years ago, the program is so successful from the preceptors’
point of view that fewer than 5 percent of them have moved on.
Equally popular is the second-year Clinical Skills program, where
students in various settings refine their communication skills and
begin performing physical exams. “The goal is primarily to help
students acquire the basic foundation for clinical practice, includ10
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“I was so lucky,” Ms. Avellino says. “I
was with Dr. Stuart Beeber [adjunct
professor of pediatrics] in my first
year. Even though he’d been in
practice for a long time, it was
encouraging to know he was still
interested in learning to be a better
physician. Throughout the year he
gave me very constructive feedback.”

This feedback and the chance to
interact with real patients are what
most excite first- and second-year students, many of whom have
long nurtured a dream that would begin with just such a pivotal
experience. For the nearly 300 College-affiliated physician preceptors scattered across New York City and the region, it’s the
chance to influence a new generation of physicians that most
inspires them to volunteer their time.

“It’s a great way to learn,” says Sara Goldgraben, Class of 2010,
whose first preceptorship was in the pediatric practice of Joshua
E. Chesir, M.D., a clinical assistant professor of pediatrics in

New City, N.Y. “It’s the first time you really get
patient interaction and individualized attention
from a practicing physician. Dr. Chesir really
took the time to guide me, giving me techniques
for taking histories that went beyond the textbook. When one patient, a nine-year-old girl,
was brought in with multiple fractures, they first
suspected abuse. It turned out that she had
osteogenesis imperfecta, a rare condition in
which children are born with very brittle bones
that can break easily. In this case, the suspicion
of abuse didn’t fit. That’s why it’s so important to
get to know your patient.”
“I didn’t get this kind of patient contact until I was
a resident,” says Dr. Chesir, a 10-year veteran
preceptor. “This not only teaches students to take
a careful history, but also gives them an early
opportunity to see how gratifying primary care
can be.”

Second-year medical students Sara Goldgraben and Gonzalo Manzano spend a lot of time
in study mode, reading and absorbing vast amounts of material. The real-world experiences
that accompanied their first- and second-year preceptorships has helped them stay focused
and motivated.

Not just book learning

“You can’t learn medicine just from a textbook,” agrees Benjamin
Dodoo, M.D., internist and clinical assistant professor of medicine,
who works for a federally funded health center in White Plains,
N.Y. Dr. Dodoo trained in England and Switzerland, and has been
a second-year preceptor for 15 years. “Sometimes students are
afraid to actually touch a patient. They think they may break something. But they do well and as time goes on they do even better,”
he says.
Lisa Bienia, Class of 2009, worked with Dr. Dodoo last year. “The
second-year preceptorship helps you learn to take a history well,
and often you can get a diagnosis just from a good history. You go
into their family history, their social history, any allergies to medications, as well as the chief complaint that brought them there.”

The skills demonstrated in the preceptorship are covered first in
class. “But learning about a heart murmur is not the same as hearing one,” Ms. Bienia says. “Dr. Dodoo helped me recognize the
symptoms of diseases that I was studying in my academic
classes. He really helped me understand that you can make a
good diagnosis most of the time by performing a good history and
physical, and not relying so much on technology.”
“The preceptorships allow students to apply what they know and
use it for practical purposes,” says preceptor Donna Phanumas,
M.D. ’94, adjunct assistant professor of medicine. A geriatrician
at The Center for Healthy Aging at Greenwich Hospital, Dr.
Phanumas recalls, “When I saw my first patient, I thought, this is
what I was born to do. Most students are like that. They are so
enthusiastic.”
“I loved working with Dr. Phanumas,” says Ms. Avellino. “I got to
do a history and a physical every week, and she helped me see
the broadest possible picture. Any time I examined a patient,
she was with me. I’m very grateful for all the effort and time she
spent with me. The preceptors teach you more than how to take
a history and do an exam—they show you how to be compassionate and listen.”

Looking beyond the immediate

“You can get tired of just reading and reading and reading,” says
Gonzalo Manzano, Class of 2010, “but when you go out there and
actually take care of patients, that gives you real motivation. At
first, all medical students are nervous about handling patients, but
through experience, it starts coming naturally. My preceptor, Dr.
Adenike Adeyemo, runs a neighborhood clinic in the Bronx. She
taught me how important it is to consider their psychological as
well as their physical well-being. If she had a sense that a patient
was depressed, she’d ask questions to get him to talk about
what was bothering him. She was always looking beyond the
immediate symptoms to see if there was something else lurking in
the shadows.

“I also learned that a lot of patients establish a profound relationship with their doctor. Dr. Adeyemo was really involved in their
lives, and the patients are loyal to her. I think that is the best way
to deal with patients. It takes those extra five or ten minutes, but in
the long run, it helps not just the patient but also your career.”
Such an appreciation for the profession is what all preceptors hope
to impart. “What we give our medical students is the reality of medicine,” says Dr. Adeyemo. “They realize that they are dealing with
human beings, people with feelings, and it’s not just about making
money and being renowned. It’s about being involved. These people place their whole lives on your lap, often at the first meeting.
You can’t abuse the trust and confidence they put in you.”

“The reading can be done anywhere; it’s the art they need to see,”
says Peter Gergley, M.D., a pediatrician in private practice in
Garrison, N.Y., and a 10-year veteran of the preceptorship program.

Students couldn’t agree more. “Sometimes you can almost get lost
in all that studying,” says Ms. Goldgraben. “The preceptor program
helps you keep your focus, and puts what you study into action. It’s
really about people.”
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FOUR STORIES:

One Common
Purpose
Graduates of the School of Medicine and the Graduate School of Basic Medical
Sciences may have had different training, but they all agree on the Food and Drug
Administration as the place where they can employ their wits and skill in service
to one of the nation’s most powerful regulatory agencies.
By L.A. McKeown
ublic service offers its own badge of
distinction—self-sacrifice, recognition and the opportunity to
achieve in a less bloodthirsty environment, for the most part. The Food and
Drug Administration (FDA) has its own
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cachet as protector of the nation’s health,
so it is no surprise that graduates of New
York Medical College have found a home
at one of the most powerful federal agencies in the country. They all acknowledge
a sense of purpose working in the federal

health sector that they rarely felt elsewhere. Their stories also showcase how
their graduate education helped them
get where they are today and keeps
them going strong.

39 years and counting
Joseph Hanig, Ph.D. ’68, M.S. ’65, has
spent nearly 40 years working at the FDA
as a research toxicologist. Shortly after
becoming one of the first to receive a doctorate from the Graduate School of Basic
Medical Sciences, he received a National
Academy of Sciences/National Research
Council postdoctoral fellowship tenable at
the FDA for two years. When that ended in
1970 he was converted to a permanent
employee and he’s been there ever since.
“The opportunity to work in the federal
setting—and the fact that the FDA has a
lot of redeeming qualities in terms of
impact on health and safety—are what
most appealed to me,” says Dr. Hanig, who
is currently associate director for research
policy in the Office of Testing and
Research (OTR). “Since then the organization has grown much larger and the
problems we are addressing are far more
complex. The science has advanced
tremendously in terms of the technology
that we can bring to bear on many different issues,” he adds.

Dr. Hanig started as a pharmacology/ toxicology researcher and progressed to project leader, group leader and deputy division director, mostly looking at
mechanisms of toxicity for various drugs.
His work has focused on trying to develop
biomarkers that predict toxicity and that
are relatively non-invasive.
Research and writing are strong personal
interests for Dr. Hanig, who has published
42 research papers in peer-reviewed journals, 4 e-journal articles and 9 books or
book chapters, and presented at numerous conferences and society meetings. He
also holds a U.S. patent for a procedure
that reduces the body burden of HIV and
other blood-borne infections.
The diversity of the applied research
involved in his work appeals to Dr. Hanig, a
benefit he believes is hard to find anywhere
but at the FDA. His work has involved toxicology studies of such high profile drugs as
hexachlorophene, cytarabine, and the headlice medication, lindane. Some consumer
groups have asked that the use of lindane in
shampoos and lotions for children with lice

“The opportunity to
work in the federal
setting and the fact
that the FDA has
a lot of redeeming
qualities in terms
of impact on health
and safety appealed
to me.”

Joseph Hanig, Ph.D. ’68, M.S. ’65
Research Toxicologist

or scabies be banned out of concerns it may
cause seizures and brain damage. Hanig
also recently started a program to develop
animal models to aid in pediatric toxicology
studies, something that he thinks is important but often is overlooked. Awareness of
age-related differences in drug susceptibility was brought home when the FDA voted
in October to ban over-the-counter cold
products for children under age 6.

Despite his busy schedule, which also
includes acting as a reviewer for various
pharmacology and toxicology journals and
holding adjunct teaching positions at
Howard University and New York Medical
College, Dr. Hanig says he greatly enjoys
his job. “The consolidated White Oak campus at FDA is almost like being at a university,” he says. “In the old days I had to
travel around a lot but now I can do
research, attend a regulatory meeting and
participate in a seminar all in one day.”

Pharmacologist finds
his niche
As a supervisory pharmacologist at the
FDA, Todd Bourcier, Ph.D.’95, M.S. ’92,
oversees a dozen pharmacologists in the
review of Investigational New Drug (IND)
applications and New Drug Applications
(NDA). They review all preclinical data,
including pharmacological and toxicological data that are important to the clinical
development and use of drugs in humans.
“We sit down and read through a 10-volume or even an 80-volume submission
that includes a lot of science data, and at
the end of 30 days we have to recommend
what dose is supported, what dose is safe
in humans, what kind of monitoring
should be employed and the general toxicological profile of the drug,” says Dr.
Bourcier, who works in the Division of
Metabolic and Endocrine Products within
the FDA’s Center for Drug Evaluation and
Research. “As more and more clinical and
pre-clinical data come in, we modify the
importance of the toxicologic studies
accordingly,” he says. The initial submission, which reviews first-in-human clinical
studies, is customarily followed by
additional, strategically timed reviews of
data submitted to support further clinical
development.
Unlike academic pharmacologists, those
in the FDA’s review division do not perform clinical or bench research. Instead,
they serve as reviewers for the huge volume of research conducted by drug companies and sponsors. For this reason, Dr.
Bourcier says anyone interested in a job
like his really should like to read—and a
thorough knowledge of pharmacology
wouldn’t hurt, either.
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“I found the
pharmacology training
I had at New York
Medical College
virtually a custommade education for
the basic principles
of the work we do
here at the FDA.”
for his family—wife Kasia, who is a fellow
scientist in the Bethesda office of the
Immune Tolerance Network, and their 5year-old daughter Hanna. “I’ve been able
to balance my work and personal life
much better in this position than when I
worked in a hospital setting,” he says.
“People who work in labs know how crazy
the hours can be. You don’t have that
here, and that’s been important for me.”

brain slice and using wavelengths of light
to capture neuronal activity.
“Hardly anybody, anywhere was doing
that. Through [Dr. Ross], we both learned
how to do [this cutting edge technique],”
says Dr. Stockbridge. “Norman and I basically sprang from that lab,” she adds.
From there, the Stockbridges went to the
University of Alberta, where they spent six
years continuing the work they began at
New York Medical College. In 1991 they
returned to the U.S., where Lisa landed a
position as a National Research Council
Senior Research Associate at the FDA. She
credits Dr. Ross with helping her gain the
experience and the recognition within the
research community that led to her FDA
position.
“I would not have been ‘acceptable material’ at the FDA had I not been given this
really broad-based education in medical
physiology,” Dr. Stockbridge says. “I don’t
know how many people appreciate how
comprehensive the program at New York

Todd Bourcier, Ph.D. ’95
Supervisory Pharmacologist

The cutting edge
“I found the pharmacology training I had
at New York Medical College extremely
helpful,” says Dr. Bourcier. “In fact, it was
virtually a custom-made education for
the basic principles of the work we do
here at the FDA.”
Before joining the agency in 2004,
Bourcier spent time at Brigham and
Women’s Hospital and Harvard Medical
School in Boston in the cardiovascular
and anesthesiology divisions as an
instructor and post-doctoral fellow, a stint
that gave him experience in grant writing
and laboratory supervision.
He says one of the factors that influenced
his decision to work for the FDA was the
access to data that really aren’t available
to anyone except those on the inside.
“The database of information that we
have, clinical and nonclinical, is just
enormous. It’s not available out there in
the literature. That is something that
really engages my interest,” Dr. Bourcier
says. Another factor is that his workload
and hours at the FDA are steady and
manageable, leaving him enough time
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Lisa Stockbridge, Ph.D. ’85, met her husband Norman, who currently directs the
FDA’s Division of Cardiovascular and
Renal Products, while both were studying
at New York Medical College. While Lisa
was working on her Ph.D. in physiology,
Norman was doing a post-doctorate in the
laboratory of William Ross, Ph.D., professor of physiology. Their focus was a new
technology that looked at action potentials
using voltage-dependent and calciumdependent dyes—dyeing a neuron or

“I would not have
been ‘acceptable
material’ at the
FDA had I not
been given this really
broad-based
education in medical
physiology.”

Lisa Stockbridge, Ph.D. ’85
Regulatory Reviewer

Medical College is, but it really ensures
that you understand every bodily system
and all its interactions. To my mind, that
is perfect for FDA work.”
Currently, Dr. Stockbridge is a regulatory
reviewer in the FDA’s Center for
Biologics Evaluation and Research. She
says her education allowed her to move
quickly into cross-cutting initiatives at
FDA. Prior to her current position, she
was the business program manager for
the initial phase of a large program
called Facts@FDA.gov, a comprehensive
internet resource designed to give onestop access for information about all
FDA-regulated products. Dr. Stockbridge,
one of the FDA’s labeling experts, has
been working on the project since 2004.
She calls it is an enormous undertaking
because it includes product labeling
information for anything the FDA regulates.
The Stockbridges have two children,
Christopher, 25, who graduated from
West Point and is a captain in the U.S.
Army, and Melissa, 20, who is studying
modern languages and linguistics at
the University of Maryland, Baltimore
County—Honors College.
Dr. Stockbridge believes her education
and career choices led her to a place
where she can make a difference. “You
really do get the feeling that you’re
doing something of consequence and
making important contributions to
your little piece of the world,” Dr.
Stockbridge says of her job at the FDA.
“You may not be able to save everybody
but you can save some people through
the work you do.”

Nephrologist likes
new challenges
Melanie Blank, M.D. ’85, spent 14 years in
solo private practice as an internist in
Virginia before going to work at the FDA in
2004. A nephrologist by training, she felt it
was time to explore other career options.
“It was partly for lifestyle reasons—it was
very difficult being in practice alone and
dealing with various pressures that most
internists face,” says Dr. Blank. “I felt like
I was being overly regulated. A colleague
who had made the transition from inter-

nal medicine practice to the FDA inspired
me and I decided to go for it.”
In 2004, she went to work for the FDA as
a clinical reviewer in the Division of
Medical Imaging and Hematology
Products. Although not her area of expertise, she found it intellectually stimulating
and cutting-edge enough to satisfy her.
Despite so many years of being her own
boss, Dr. Blank said she has much independence in her job and feels free to express
her opinions and recommendations.

As a clinical reviewer, Dr. Blank and her
colleagues make determinations about
the safety and efficacy of drugs at various
phases of development. “It’s really very
exciting when you consider we do a lot to
protect the public’s health,” she says. “Our

“It’s really very
exciting when
you consider
we do a lot to
protect the public’s
health.”
“There are certain similarities to working
in a practice,” Dr. Blank says. “Sometimes
you call the shots but other times you
don’t. And you have a lot of consensusbuilding, which is important in both situations. I think the way we work together at
the FDA is quite similar to what I was used
to in practice in terms of collegial collaboration and trying to do what is best for the
public health, in this case, as opposed to
the patient.”
If being relieved of the pressures of running a business is a plus, then not having
to deal with insurance companies or be
on-call are two more advantages. In addition, the pay is good and the hours are
more flexible, both important to Dr. Blank,
who is a single mother of two teenagers.
“All around, I see this as being a very positive move for me,” she says. Although the
FDA allows its physicians professional
development time in which they can continue to practice on a limited basis, Dr.
Blank says she is satisfied with her clinical
medicine experience and doesn’t feel the
need to continue to see patients, although
she admits to missing it on occasion.

Melanie Blank, M.D. ’85
Senior Clinical Reviewer

decisions are far reaching and that gives
me a real sense of satisfaction. I think I
feel that more here than I did in private
practice.”
She is excited about her upcoming move
to the FDA’s Division of Cardiovascular
and Renal Products, where she will be
involved with the clinical qualification of
renal biomarkers for renal injury, a new
and exciting area that promises to be a
factor in future center-wide drug development. “That’s going to tie everything
together for me,” she says.
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THE ACCIDENTAL
GASTROENTEROLOGIST
How Nicholas F. LaRusso, M.D.’69, turned
opportunity into success—and found his
way into the medical lexicon with his
pioneering studies of liver disease.

By Andrea Kott, M.P.H
icholas F. LaRusso, M.D. ’69,
does not seem like the type of
man who would discover his
life’s work by accident. The renowned
physician and scientist has had the kind
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of success that would seem the result of
deliberate planning. Yet the work that has
ultimately become Dr. LaRusso’s passion—innovative care of patients with
liver disease and epithelial cell biology—

found him, rather than the other way
around. He has become one of the nation’s
top gastroenterologists and research scientists, making giant leaps in the study of liver
disease, a leading cause of death in the U.S.

While the American Gastroenterological
Association (AGA) has affectionately
named Dr. LaRusso, its 102nd president,
the “accidental gastroenterologist,” there
has been nothing unintended about his
scientific contributions. Most notable of
these is his role in studying the cholangiocyte, the epithelial cell that lines the bile
ducts in the liver, and its role in the cholangiopathies, a group of serious and often
life-threatening liver diseases in which the
cholangiocyte is the principal target of a
variety of pathologic processes. He has, in
effect, established the field of cholangiocyte biology. “We coined the term cholangiocyte and it is now in Stedman’s Medical
Dictionary. It was not there 10 years ago,” Dr.
LaRusso says.
Born and raised in Brooklyn, N.Y., Dr.
LaRusso graduated magna cum laude from
Boston College. After earning his M.D. at
New York Medical College and doing a
medicine internship at Metropolitan
Hospital Center in Manhattan, he completed his training in internal medicine
and gastroenterology at the Mayo Clinic
in Rochester, Minn. Then, opportunity
knocked. Alan F. Hofmann, M.D., Ph.D., Dr.
LaRusso’s scientific mentor and a worldrenowned clinical investigator, helped him
land a spot as a guest investigator in the
department of biochemical cytology at
Rockefeller University in New York City.

Trained by the best
In 1977, after two years at Rockefeller in
the laboratory of the Nobel laureate
Christian DeDuve, Dr. LaRusso accepted a
faculty appointment in the division of gastroenterology and hepatology back at the
Mayo Clinic, where he began his career as
an independent physician scientist and
epithelial cell biologist. He initially
focused on a little-understood adult
cholestatic liver disease—primary sclerosing cholangitis (PSC)—which had a very
poor prognosis before liver transplantation. “In the late 1970s and early 1980s,
when people developed advanced liver disease as a result of PSC, they all died. It was
pretty discouraging,” he rues.
Meanwhile, Thomas E. Starlz, M.D., Ph.D.,
a pioneer in liver transplantation at the
University of Pittsburgh, began using
cyclosporine as an immunosuppressive
agent after liver transplantation. “We at
Mayo became very interested. We con-

nected with Dr. Starlz and began to refer
patients to him for transplant,” Dr.
LaRusso says. In the mid-1980s, he and
his colleagues decided to start Mayo’s
own liver transplant program, which today
operates in the headquarters as well as at
the clinic’s two other main locations in

practice. The ultimate goal is trying to
understand and positively influence disease development and progression.”

Ready for anything
Dr. LaRusso credits his undergraduate
medical education for the quality of his
clinical training. “I learned how to be a
scientist at Mayo and Rockefeller. What I
learned at New York Med was how to be
a good doctor,” he says. “I learned how to
take care of sick patients, to deal with
medical emergencies, and to handle a
diverse patient population. When I came
to Mayo, I felt confident I could deal with
whatever came along.”
His credentials are impressive: he is the
Charles H. Weinman Endowed Professor
of Medicine at the Mayo Clinic, chair of
the Department of Medicine at the Mayo
Clinic College of Medicine, and a distin-

In his 30 years at the Mayo Clinic, Nicholas F.
LaRusso, M.D. ’69, has built a reputation for
gastroenterological research and patient care,
and helped pioneer the study of the
cholangiocyte.

Scottsdale, Ariz., and Jacksonville, Fla.
“Our transplant program is one of the
largest in the country with some of the
best outcomes,” he adds.

Breaking new ground
Dr. LaRusso and his colleagues pioneered
new approaches in the study of cholangiocytes, including methods to isolate
highly purified bile duct epithelial cells
from rodents, human and rodent cell culture systems, cell fractionation techniques
and perfused bile duct models.
In some cystic liver diseases, bile ducts
expand and become like basketballs
instead of their usual form, a long, hoselike tube. And in some conditions the bile
ducts become highly inflamed, which
leads to scar tissue and cirrhosis. “We
know these cells are involved but the
processes that result in their becoming
abnormal differ. And we barely understand
how any of these processes happen. That’s
what my research focuses on,” he says.
Still, research comprises only one aspect of
his professional life. Describing himself as
a physician-scientist, he says, “I do
research, but my research is linked to my

“What I learned at
New York Med was
how to be a good
doctor. When I came
to Mayo, I felt
confident I could
deal with whatever
came along.”
guished investigator of the Mayo
Foundation. He is also an NIH funded
investigator and recipient of a prestigious
MERIT Award; former editor of
Gastroenterology; and
recipient of
Distinguished Achievement awards from
the AGA and the AASLD, as well as the
AGA’s Distinguished Mentor Award.
Dr. LaRusso becomes ebullient when
talking about the future, which he sees
as full of possibilities. Says the
marathon runner and father of four
grown children, “I want to stay healthy,
to be able to keep coming to work and
making a difference. If I continue to be as
fortunate as I’ve been in the past, that
would be great.”
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Pharmaco-WHAT?
Her current job title may inspire a little good-natured
ribbing—along with some questions—
but Nasiba Abdul-Karim, M.P.H. ’04, is serious about
her passion for drug safety.
By Bill McDaniel
he is a manager of pharmacovigilance. The phrase conjures up

effects, particularly long-term and shortterm side effects of medicines.

images of some Orwellian drug
ministry straight out of the novel 1984,
dedicated to making sure we all take our
meds on time. You won’t find it in most dictionaries, but according to the online
mega-reference Wikipedia, pharmacovigilance is the science of detecting, assessing,
understanding and preventing adverse

But in describing her job with its intriguing
title, Nasiba Abdul-Karim, M.P.H. ’04, puts
it this way: “It’s all about drug safety and
taking a holistic look at how patients and
groups of patients react to the medications
they take.” That has been her all-consuming passion since receiving a B.S. in

S
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Biology from Spelman College and going
to work for Forest Laboratories in Jersey
City, N.J., where she was assigned to the
company’s drug safety unit tracking
instances of adverse drug reactions (or
ADRs), “almost by chance.”
Because clinical trials involve relatively
small numbers of patients, less common
side effects and ADRs (including severe

ADRs such as liver damage) are often
unknown at the time a drug enters the
market. And given the proliferation of medications today, drug interaction has
become a major concern. Being on the
lookout for potential hazards when medications are combined has become a
necessity, although the investigations
unfortunately often come after a report of
an adverse reaction.
“I became interested in digging into
instances of adverse drug reactions to find
out what was going on,” she says. “It was like
detective work. I enjoyed the research and
searching for clues, connections and
answers. That became my motivation to get
my master’s degree. And since I’m a New
York City woman, the School of Public Health
at New York Medical College was the right
choice for me.”
Since graduating with her M.P.H. in
epidemiology, Ms. Abdul-Karim’s career
has focused on drug safety. From her job at
Pfizer, where she worked briefly after graduation, to The Medicines Company where, as
manager of drug safety, she created company procedures to ensure compliance
with FDA regulations, she has held increasingly responsible positions in the field of
drug safety, or pharmacovigilance.
Her career path has now led her
to Celgene Corporation, a biopharmaceutical company headquartered in Summit,
N.J., that manufactures a number of innovative therapies to treat cancer and
immunological diseases. One of them,
thalidomide, is notorious for having
caused devastating birth defects when taken
by pregnant women in the early 1960s.
Today, the FDA does not allow general sale
of thalidomide but, with significant
restrictions and careful monitoring by
people like Ms. Abdul-Karim, does allow
its use in studies of certain severe or lifethreatening diseases where there may be
no other treatment.
As a result, Celgene requires those
who prescribe and dispense its products to
register in a special distribution program,
which allows the company to closely monitor usage by patients and prescribers.
Though pre- and post-marketing drug
safety programs are mandated by the FDA,
all pharmaceutical companies approach

She realized that
what she truly
wanted went beyond
her girlhood dream
of being a doctor.
She made the classic
leap to a public
health focus:
populations rather
than individuals,
prevention rather
than treatment.
this requirement differently, with varying degrees of rigor. Ms. Abdul-Karim’s
approach is most definitely proactive
and rigorous. She uses an internal drug
safety database, composed of reports
from physicians, hospitals, pharmacists
and patients, to actively assess the
safety of these participants on a regular
basis. She also monitors and collects
information for her periodic safety
reports to the FDA and international
authorities such as the European
Medicines Agency.
“While getting my degree, I decided on
a concentration in epidemiology,” Ms.
Abdul-Karim says, “because it is an ideal
field of study for anyone interested in drug
safety. Epidemiology focuses on research
methodology and evidence-based medicine for identifying risk factors. Just as epidemiologists use research and analysis to
identify causal relationships between exposures and outcomes, so do those of us
interested in drug safety rely heavily on
research and analysis to identify the causes
of adverse drug reactions. That’s where the
detective work comes in.”
Growing up in a close-knit neighborhood
in New York City, her dreams and ambitions centered on cardiology and surgery.
She volunteered in New York Hospital’s
Nuclear Cardiology Research Department,
Harlem Hospital’s Pediatric Center, as well

Nasiba Abdul-Karim, M.P.H. ’04, investigates
the long- and short-term side effects of
medicines for a company that manufactures
innovative therapies for treating cancer and
immunological diseases.

as many non-profit youth and health outreach programs.
But at some point she realized that what
she truly wanted went beyond her girlhood
dream of being a doctor. She made the
classic leap to a public health focus: populations rather than individuals, prevention
rather than treatment. “I wanted to impact
the patient’s life as a whole; to advocate for
patients in ways they could not advocate
for themselves and to advocate for good
health practices on a larger scale,” she said.
“And most definitely I love making a
difference. If I notice something new or different going on—some different correlation
or factor—hundreds, maybe thousands of
lives can be saved.”
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Ira Schwartz, Ph.D., Turning 60, Knows
The Best is Yet to Come
(continued from page 5)

expression, which is not yet in use to diagnose any infectious disease.”
Before there was DNA, there was just chemistry, which became Ira Schwartz’ passion in
the eighth grade, though he still doesn’t
know why. “It must be the chemistry set I
was given at the age of 10,” he jokes. “All I
know was that balancing equations was
easy and I absolutely loved organic chemistry.”
There was another love in his life that would
co-exist all the days of his life. Growing up
on Manhattan’s Lower East Side, Dr.
Schwartz attended the first full-time Jewish
day school in the U.S.—the Rabbi Jacob
Joseph School established in 1900. “My entire
education combined secular and religious
studies. Even in undergraduate school I took

“A department is like
a body. Every organ
has its own function,
and when they all
function together
the body is healthy.”
two full-time courses of study, but I did it for
intellectual and religious reasons. At no time
did I ever contemplate becoming a member
of the practicing clergy,” he says.
“Being strictly observant has never posed a
problem because as a person of faith, there
are things I just don’t compromise on, such
as a strict observance of the Sabbath. I’ve
also tried to keep these two aspects of my
life separate,” says Dr. Schwartz. “I’m not
here as a rabbi who happens to be a microbiologist. I’m here because I have a Ph.D.
and I do basic science research—which has
nothing to do with the fact that I have a rabbinical degree.”
Dr. Schwartz married in 1968 after earning
his undergraduate degree. He had met
Arlene when she was 17, and a student at
the Bronx High School of Science. A therapist with a master’s degree in social work,
she is currently a supervisor in the behavioral health division at Good Samaritan
Hospital, a College affiliate, in Suffern, N.Y.
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They have three children—Kenneth, an
assistant headmaster (and ordained rabbi)
at a private Jewish day school in Manhattan;
and daughters Aliza and Rina, who teach
middle school. The oldest of eight grandsons is only six, yet grandpa is already
counting the bar mitzvahs in his head.
Dr. Schwartz earned his B.S. degree in
chemistry at the City College of New York
and followed with his Ph.D. in biochemistry
from the City University of New York. His
thesis dealt with the interaction of the antitumor drugs adriamycin and daunorubicin
with DNA, but his post-doc at the Roche
Institute of Molecular Biology in Nutley,
N.J., focused on the workings of protein
synthesis. When the post-doc concluded,
Dr. Schwartz accepted the post of assistant
professor of biochemistry from the
University of Massachusetts at Amherst.
But after five years in New England, the
Schwartz family felt something was still
missing. In 1980 they returned to New York.
Dr. Schwartz joined the College as assistant
professor of biochemistry, and when Lyme
disease began to flourish in Westchester
County, he discovered “an unexplored area
that was so exciting I decided to take up a
new challenge.”
From any viewpoint, remaking the Department of Microbiology and Immunology has
been a monumental task. But “the faculty
have bought into what I have laid out and
things are going quite well,” he says. “A
department is like a body. Every organ has
its own function, and when they all function
together the body is healthy.” Besides rejuvenating his own department, Dr. Schwartz
chairs the Research Support Services
Committee of the Faculty Senate, an advocacy group that lobbies for the research
faculty on administrative issues that include
purchasing and accounting, research infrastructure such as comparative medicine
and other core facilities, and services like
the bookstore.
As one who is known for being open to multiple points of view and a champion of his
colleagues and their research, Ira Schwartz
is a working scientist who still believes passionately that there is no higher calling.
“I am engaged in discovery every day. When
I look at the sequence of a gene and realize
I’m the first one to sequence it, I’m blown
away!” he admits. “To realize that I am the
first human being to have figured out this
information leaves me just as excited about
that today as I was 30 years ago.”

From Shanghai to Innsbruck to
Valhalla… a Scientist Follows his Bliss
(continued from page 7)

working with four Ph.D. students; three are
women. For the record, Dr. Wang does not
agree with former Harvard University president Lawrence H. Summers, who in 2005
unleashed a storm of controversy when he
suggested that there are biological differences between men and women that might
help explain women’s underrepresentation
in the higher echelons of science and technology. “You cannot generalize,” says Dr. Wang
firmly. “It really depends on the person.”
As to whether he prefers research or teaching, Dr. Wang says he enjoys both because
they naturally complement each other. “I
really like to interact with students and especially to help them develop their gifts and talents,” he says. Also, “with research, you study
one field quite narrowly; you lose the big picture. Teaching forces you to learn new things.”
He adds that there is so much happening in
science today, it’s important to keep up. “If
you don’t refresh yourself, after a few years
your knowledge will be outdated,” he says.
“Teaching also helps you understand what’s
going on in new areas, and which techniques
and knowledge you can bring back and use in
your own research.”
In thinking about his scientific legacy, Dr.
Wang says his goals are relatively modest:
“The word legacy is too much for me.” What
he wants is to continue working and publishing scientific papers that he hopes will
make “small” breakthroughs. “I hope I can
contribute something to kidney science, to
do something meaningful while I’m having
fun. In science you never can say, I have
learned enough. There is always something
more; your mind is active; your hands can do
something; you can work, you can read, you
can think,” he explains.
That’s not to say Dr. Wang spends every waking hour peering through a microscope or
standing at the front of a classroom. At
home he enjoys reading about politics and
listening to classical music, especially
Mozart. “When I listen I feel very relaxed,” he
says. He also makes time to return to China
at least once a year to visit his mother, who
is 93, and to teach and serve as a guest lecturer at Chinese medical schools.
Dr. Wang has this advice to up and coming
students who are making decisions about
their careers: “Pick up something you like
and stick with it,” he urges. “If you don’t
like it, you cannot do it well.”

James P. Angiulo, M.D. ’72
By Andrea Kott, M.P.H.

White coat, suit jacket, black
robe. Doctor, lawyer, judge. As
all three, James P. Angiulo,
M.D. ’72, has dedicated himself to helping others, keeping
a hand in each trade all the
while.
Not everyone has the fortitude
to pursue more than one
major career path in life, especially when those paths
include medicine and law. But
it was more than the lure of
the professions that compelled Dr. Angiulo; it was his
love and admiration for his
father, a lawyer, and his uncle
and godfather, an osteopath,
that steered him first toward
medicine and then law.
“The common ground between
medicine and law and the
judiciary is trying to help
people,” said Dr. Angiulo, who
uses the nickname “Judge
Jim.” As a lawyer he advocated for clients. As a judge

he evaluates the evidence
before him to make good
decisions. As a physician he
examines lab tests, x-rays,
and EKGs to make the right
clinical decisions. “In all three
cases the objective is to help
a human being,” he said.
Truth be told, Dr. Angiulo, an
anesthesiologist, always
wanted to be a lawyer. “When
I grew up, like most kids, I
wanted to be like my dad,” he
said. But starting up a law
practice in 1941 did not offer
financial stability, so his father
worked at a Queens, N.Y.,
post office during the week.
“On Sundays we would go to
his law office,” Dr. Angiulo
said. Meanwhile, Dr. Angiulo’s
Uncle Pat was practicing
anesthesiology in Tucson,
Ariz., a world away from the
concrete jungle he knew
growing up.
He recalled one visit when he
was a pre-law student at St
John’s University in Jamaica,

After earning his M.D. at New
York Medical College and
completing training in anesthesiology at the University of
Florida in Gainesville, Dr.
Angiulo continued to follow
his uncle’s footsteps all the
way to Tucson. By then a husband and a father, he began
practicing obstetric anesthesiology at the University of
Arizona in 1975 and became
chief of anesthesiology two
years later at Kino Community
Hospital in Pima County,
where he stayed until 2000.
Although Dr. Angiulo enjoyed
medicine, his passion for law
tugged at him. “I always had a
burning desire to be an attorney,” he said. Instead of leaving one field for another, he
decided to practice both.
From 1982 to 1985, while
working night shifts at the hospital, Dr. Angiulo attended the
University of Arizona College
of Law, where he graduated
with highest distinction. “I never
would have been able to do
that without the support of my
loving wife, Nina, and my children, who made sure to ‘keep
it quiet while Daddy was
studying,’” he said. He passed
(continued on page 27)

N

Dr. Angiulo said his uncle
mentioned things that can
“strike a chord in a young
man,” such as making a lot of
money, getting married and
settling down. “One thing led
to another and I started to
respect that there are more
people than Dad to look up
to,” he said. “Next thing you
know, I switched my major
from pre-law to pre-med.”

A

Lance Fairchild Photography

N.Y. “Uncle Pat said, ‘Why
become a lawyer when you
can become a doctor? You’ll
be better off financially.’”

LUMNI

A MAN OF MANY COATS
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James P. Angiulo, M.D. ’72:
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SPEECH-LANGUAGE
PATHOLOGIST TURNED AUTHOR
Michele Zucker Saunders, M.S. ’01:

Officers

By Andrea Kott, M.P.H.

President

Michele Zucker Saunders,
M.S. ’01, has a fond memory
of first grade. She was working with a speech therapist to
correct her articulation of the
“s” sound. Ms. Saunders
recalls looking forward to the
game playing,
rhymes and
books that comprised her therapy. “It was such
an enjoyable
experience and it
put me on the
path to a career I
truly love,” she
said.
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That vivid memory, along with the
inspiration that
came from having
a mother who was
a teacher, fueled
her own interest in
pursuing a career
in speech-language pathology.
“Helping others and
teaching others has
always been something I
aspired to do,” Ms. Saunders
said.
Ms. Saunders graduated from
the inaugural class of the
Speech-Language Pathology
Program in the School of Public
Health. Throughout her career
she has worked in a variety of
settings, including clinics and
hospitals, special education
preschools, elementary schools,
high schools, and most recently,
a public middle school in
Rockland County, N.Y., where
she lives. She works with typically developing children as
well as children with developmental delays or disabilities.

Some of her students have
relatively straightforward and
simple articulation issues, like
a lisp. Others come with a
range of developmental
disabilities, such as autism
disorder, Asperger’s syndrome,

Michele Zucker Saunders, M.S. ’01

learning disabilities, Down
syndrome, speech or language impairments, fluency
or voice disorders, or some
variation of pervasive development disorder, also known
as PDD. “The scope of the
practice for speech-language
pathologists over time has
grown and expanded,” Ms.
Saunders said.
To meet the varying needs
and abilities of people with
speech-language challenges,
Ms. Saunders has written a
six-book series called “Autism
and PDD: Things I Can Say
and Do”, published by

LinguiSystems, Inc. “As a therapist, you’re always looking to
find students’ strengths and to
work with those to help them
achieve the goals they need to
reach,” Ms. Saunders said.
The series is directed largely
to speech-language
pathologists, therapists, and special
education teachers.
Published in August
2006, the books are
arranged according
to the activities of
daily living “Body
Parts and Clothing,”
“Feelings and
Actions,” “Holidays,
People and Places,”
“Staying Clean and
Healthy,” and
“Weather, Seasons
and Months.” They
use communication
and activity “webs,”
visual diagrams that
contain sentences
and actions that children might say or do in
a variety of contexts and are
designed to help children initiate appropriate conversation
and behaviors.
For example, the “Feelings
and Actions” book has a communication web titled, “Things
I Can Say When I Need a
Break,” and an activity web
titled, “Things I Can Do When
I Need a Break.” The web also
provides a variety of suggested sentences and behaviors appropriate to the situation. A child may learn how to
say, “I want to stop” or “I’m
tired” when she needs a break;
similarly, she may learn to go
for a walk or do a puzzle.

ALUMNI
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Two Thousand Five
While the series can be used
with an array of students with
developmental disabilities, it is
particularly effective with children with autism, who do best
with concrete and literal tasks.
“Autism is an area where we’re
constantly looking for techniques and therapy ideas to
help students access and initiate language,” Ms. Saunders
says. “These activities give
students actual sentences to
use in a variety of contexts
they face throughout their
daily lives.”
Each book also provides
blank web templates that
allow the teacher or therapist
to customize activities to each
student’s language and social
skill levels and to personalize
lessons to match a student’s
specific communication situation or needs.
Ms. Saunders wrote the entire
series while on maternity leave
with her infant daughter. She
has a second series in production, “Autism and PDD: Tell
Me About It.” The five-book
series is scheduled for publication in August 2008.
Besides fulfilling her love of
writing and her longtime
dream of getting published,
writing the series has also
given Ms. Saunders another
way to reach children or anyone in need of new and creative communication strategies. “It’s something I’ve
always wanted to do,” she
said. “Sometimes you’re just
supposed to do something
and it works.” ⽧

Claudia F. Califano, M.D. ’05, is happily
settled in the New Haven area, loving
Yale, and married to Kevin P. Becker,
M.D., Ph.D., a neurologist. “Best wishes
and deepest gratitude to all at NYMC!”
Heidi M. Dambach, M.D. ’05, reports
that Jeremy Stupin, M.D. ’05, has transferred back to California for his residency at the University of California, San
Diego; Ken Chong, M.D. ’05, has a oneyear old toddler; Clara Lo, M.D. ’05, will
be starting her fellowship in July 2008;
and, Kristin Belen, M.D. ’05 is getting
married in November 2007.

Two Thousand Four
Julia M. Braza, M.D. ’04, is engaged to
Anthony Martyniak, M.D., a fellow
pathology resident at Beth Israel
Deaconess Medical Center in Boston.
The couple plans to marry next August
on Cape Cod, Mass.
Steven Kananan, M.P.H. ’04, writes
that the National Association of EMS
Physicians accepted his thesis for a
poster presentation in January 2006.
The National Association of EMS
Educators selected Mr. Kananan to create educational standards for EMS
response to weapons of mass destruction and terrorism. He was also
appointed chair of the research committee for the National Association of EMS
Educators.
Candace D. Poff, M.P.H. ’04, is beginning her fourth year of medical school
and will be participating in the 2008
Match and applying to Westchester
Medical Center. Poff and husband
Patrick Drew Hinote have a year-old son,
Palmer.

Two Thousand Three
John J. Panagotacos, M.D. ’03, completed his residency in neurology at
UCLA and is starting a fellowship there
in vascular neurology (stroke).

Two Thousand Two
Anne M. Faustin, M.P.H. ’02, is regional
vice president for the American Cancer
Society (ACS) in the Bronx. Previously,
she was senior director of the ACS
healthcare systems and collaborations
division.
Amy Windrum Maragioglio, M.S. ’02,
married Chuck Maragioglio in 2003 and
gave birth to Charles “Charlie” Tracy

Maragioglio in July 2005. She is working
part-time at Island Sports Physical
Therapy of Coram on Long Island.

Two Thousand One
Theodore Kutzy, M.D. ’01, completed his
residency in internal medicine at Lenox
Hill Hospital in 2004 and a fellowship in
palliative care at the James J. Peters V.A.
Medical Center in the Bronx in 2006. Dr.
Kutzy is medical director for Compassionate Care Hospice. He is also a New
York State certified medical acupuncturist.
Arie E. Pelta, M.D. ’01, has completed a
colon and rectal surgery fellowship at the
Georgia Colon and Rectal Clinic in Atlanta
and has joined the practice as a colon
and rectal surgeon. The clinic’s senior
partner is Guy Oranio, M.D. ’79. Dr. Pelta
and wife Alyssa have three children:
Avigayil 5, Elisheva 4, and Yehuda 3.
Timothy M. McClung, M.P.H. ’01, is a
fellow of the American College of
Healthcare Executives. To obtain this status, he had to fulfill multiple requirements, such as meeting academic and
experiential criteria, earning continuing
education credits and demonstrating professional/community service. Presently,
he is a director of operations improvement at Norwalk Hospital in Conn.

Two Thousand
Lauren A. Bumby, M.D. ’00, is practicing
internal medicine in Ridgefield, Conn.
Previously, she worked for Saint Vincent’s
community medicine department, serving
as medical director of a clinic at the
largest men’s homeless shelter in New
York City.
Vanessa A. Ribaudo Kaufman, M.D. ’00,
is working in the department of pulmonary and critical care medicine at
Lehigh Valley Hospital in Allentown, Pa.
Peter Kofitsas, M.S. ’00, has written and
published a book, Live Better Journal. Mr.
Kofitsas was named “National Health
Expert” by Fitness magazine in 2006 and
appeared on the Lance Armstrong
Learning Channel special, Running for
Life.
Matthew G. Pinto, M.D. ’00, has completed a fellowship in pediatric critical
care at Schneider Children’s Hospital in
New Hyde Park, N.Y., and has joined the
faculty at NYMC as assistant professor of
pediatrics in the critical care division of
Maria Fareri Children’s Hospital.

The Nineties
John K. Chan, M.D. ’97, is an
attending physician in the department of ophthalmology for Kaiser
Permanente in Hayward, Calif. Dr.
Chan is also clinical instructor in the
department of ophthalmology at the
California Pacific Medical Center in
San Francisco.
Scot G. McAfee, M.D. ’97, directs
the adult psychiatry-training program
at St. Vincent’s Hospital in
Manhattan.
Sunit H. Patel, M.D. ’97, and wife
Samantha announce the birth of twin
girls, Angela and Alexandra, born
August 16, 2007. Dr. Patel lives and
practices pediatrics in Westerly, R.I.
Bradley S. Cash, M.D. ’95, is medical director of Spine Options in
White Plains, N.Y., and is pleased to
announce the opening of a second
location in Eastchester for nonsurgical care of neck and back pain.
Po Ching Fong, M.D. ’95, is practicing obstetrics and gynecology in
New York City. She and her husband
have two children.
Catherine G. Winkler, M.P.H. ’95,
works at Danbury Hospital in nursing
administration. She is a doctoral
candidate at Yale University, where
she also has a teaching fellowship.
She expects to graduate in July
2008.
Mokarram Jafri, M.D. ’94, is chair of
anesthesia at Saratoga Hospital in
Saratoga Springs, N.Y.
Joanne P. Starr, M.D. ’90, is
director of cardiothoracic surgery at
Children’s Hospital of New Jersey in
Newark. Dr. Starr also leads a medical team to the Dominican Republic
each year to perform heart surgery
for congenital defects, as part of the
International Children’s Heart
Foundation.

The Eighties
Michelle A. (Grosz) Multz, M.D. ’87,
reports that daughter Rachel is in
middle school and “thinks she
knows everything,” while son Daniel
is a “big first-grader.”
Hollis G. Potter, M.D. ’85, chief of
the division of magnetic resonance
imaging at the Hospital for Special
Surgery in Manhattan, has been
named one of New York City’s Best
Doctors.
(continued on page 26)
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Reunion Weekend

And Remember Medical School Days
ALUMNI HONOR THEIR PEERS

holding the rank of Lieutenant
Colonel, and is an emergency
physician in the Maryland
Bioterrorism Unit. His career
has also included stints on
the faculty of the University of
Texas M.D. Anderson Cancer
Center in Houston, Harvard
Medical School, University of
Pittsburgh School of Medicine,
University of Texas Health
Science Center at San Antonio
and Georgetown University
Medical Center.

By Lori-Ann Perrault

Old friends were reunited and
new acquaintances were
made amid the art deco trappings of the Waldorf-Astoria in
New York City on May 19,
when the College hosted its
annual alumni banquet and
awards presentations. The following day the celebration
moved north to the Valhalla
campus where a reunion
luncheon was held for the
Classes of 1942, 1947, 1952,
1957, 1962, 1967, 1972, 1977,
1982, 1987, 1992, 1997 and
2002.
At the banquet, members of
the Class of 1957 and the
Class of 1982 were awarded
gold and silver diplomas.
The evening served as an
occasion to honor two alumni
with an Alumni Association
Medal of Honor, the highest
recognition awarded by the
Alumni Association.
Every year since 1948 New
York Medical College has
honored distinguished alumni,
nominated by their alumni
peers and selected by the
Alumni Board of Governors,
for significant contributions in

The 2007 Alumni Medal of Honor recipients Scot C. Remick, M.D. ’82,
left, and John M. Jessup, M.D. ’72, proudly displayed their solid
bronze die-struck medallions.

medicine and academic
achievements. A glimpse at a
list of past medal of honor
recipients reveals prominent
physicians, educators, scientists and researchers. This
year’s recipients are no exception: John M. Jessup, M.D. ’72,
and Scot C. Remick, M.D. ’82.

Flanked by College and Alumni Association leadership, John A. Braca III,
M.D.’07, center, received the Alumni Endowed Scholarship for Scholastic
Excellence and Community Service. From left: Ralph A. O’Connell, M.D.,
provost and dean of the School of Medicine, Christopher F. X. Riegler, M.D. ’88,
president of the Alumni Association and member of the Board of Trustees,
Louis E. Fierro, M.D. ’60, immediate past president of the Alumni Association
and member of the Board of Trustees, and Karl P. Adler, M.D.,
president and chief executive officer.
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Dr. Jessup is currently chief of
the Diagnostics Evaluation
Branch of the Cancer Diagnosis
Program at the National Cancer
Institute in Rockville, Md. He
has served in the United
States Public Health Service,
the Maryland Defense Force

Dr. Remick is the director of
the Mary Babb Randolph
Cancer Center at West
Virginia University, a position
he assumed last summer.
Prior to that he served as the
Dr. Lester E. Coleman, Jr.,
Chair in Cancer Research and
Therapeutics at Case Western
Reserve University School of
Medicine in Cleveland, Ohio,
and as associate director for
clinical research at the Case
Comprehensive Cancer
Center in Cleveland. He has
published more than 153
papers. To date, his research
has generated more than $15
million in grant awards. ⽧

Gold diploma recipients were happy to reminisce with their former
classmates and friends from the Class of 1957. Back row from left:
William Brown, M.D., Michael Daly, M.D., Charles Aswad, M.D.,
Donald Bradley, M.D., Richard Cobb, M.D., Joan Easton, M.D.,
Charles Kilhenny, M.D., E. Arthur Livingston, M.D., Harold Reikes, M.D.,
and Robert Martin, M.D. Center row: William McCully, M.D.,
William Cleary, M.D., John DeAngelis, M.D., Mark Anapoell, M.D.,
Murray Pozner, M.D., John Spring, M.D., John Harrison, M.D., and
Lawrence Smith, M.D. From row: Thomas March, M.D., Owen Heninger, M.D.,
Wallace Rooney, M.D., S. Ross Mackay, M.D., John Tracy, M.D.,
Arthur Zimmerman, M.D., Jerry Weisfogel, M.D., and William Donnelly, M.D.

ALUMNI
Reunion Weekend

Gone By At 25- and 50-Year Reunions

Members of the Class of 1982 were awarded
silver diplomas marking 25 years since they received
their medical degrees. Back row from left: Buff Greider, M.D.,
Donald Harrell, M.D., James Woodburn, M.D., Michael Campion, M.D.,
Jeffrey Matican, M.D., Vincent LaDelia, M.D., Michael Rogers, M.D.,
Kenneth Egan, M.D., and Daniel Wapner, M.D. Third row:
Howard Quentzel, M.D., Ralph Falk, M.D., Barry Karon, M.D.,
Harriet Dickenson, M.D., Beth Kalman Karon, M.D., Philip Ragone, M.D.,
Edward Herman, M.D., and Malcolm Roth, M.D. Second row:
Vincent Panella, M.D., Gary Rosman, M.D., Lawrence Fein, M.D.,
Joseph Lobl, M.D., Robert Troiano, M.D., Robert Perelman, M.D.,
Jeffrey Krupen, M.D., Donald McCord, M.D., James Friedman, M.D.,
Robert Jason, M.D., and Alan Morelli, M.D. Front row: Andrew Simon, M.D.,
Scot Remick, M.D., Joseph Calandra, M.D., Ann Esposito Anderson, M.D.,
Joseph Cerbone, M.D., Anne McVeigh, M.D., George Tsimoyianis, M.D.,
David Kelly, M.D., Daryl Altman, M.D.,
and Jay Tartell, M.D.

At the Alumni Reunion luncheon, an old yearbook promoted laughter
and memories for these former classmates from the Class of 1957:
Lawrence R. Smith, M.D., Richard Cobb, M.D., Mike Daly, M.D.,
George R. Monahan, M.D. and S. Ross Mackay, M.D.

Attending their first five-year reunion were these members of the
Class of 2002. From left: Shephard Kosurt, M.D., Joseph Giamelli, M.D.,
Michael Sergi, M.D., and Mason Oltman, M.D.

Erica Cargill Jones, M.D. ’92, brought her daughters,
Fiona, age 6, and Serena, age 13, to her alma mater
for the luncheon.

Joseph M. Wu, M.D., left, professor of microbiology and
immunology, welcomed Harold Reikes, M.D. ’57, and his wife Mary
to the Valhalla campus.
– Photos by John Vecchiola –
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M I L E S T O N E S
(continued from page 23)
William F. Varr III, M.D. ’84, has a private ophthalmology practice in Warwick,
R.I. He writes that daughter Elizabeth, 22,
has graduated from Boston University,
where daughter Meredith 20, is a sophomore. Daughter Alaina, 20, is a sophomore at the College of Charleston.
Amy Batterman Ditchek, M.D. ’83, says
“Hi to all,” and reports that all is well in
Brooklyn. “I can’t believe it will be 25
years since graduation! I will try to attend
the celebration.”
Deborah Fried, M.D. ’83, writes, “Many
of the Class of ’83 probably agree that 50
is the new…um…29? May we all age
with grace and style.”
Harriet Dickinson, M.D. ’82, attended the
25th anniversary dinner and luncheon
and “had a great time!”

The Seventies
Harmon C. Stein, M.D. ’79, is performing
cataract and Lasik surgery in his Bucks and
Mercer County offices in Pennsylvania.
Sons Justin, 28, just got married and
Seth, 19, is studying at the University of
Rochester and volunteering in Guatemala.
Daughter Jillian, 16, performed offBroadway and is attending the Lawrenceville School near Princeton, N.J.
Charles F. Lanzieri, M.D. ’78, is interim
chairman of radiology at Case Western
Reserve University in Cleveland, Ohio.
Greta Daun, M.D. ’77, lives and practices
medicine in New York City.
Lloyd Haskell, M.D. ’77, has been working in the pharmaceutical industry for 20
years and is vice president in the internal
medicine group of Johnson & Johnson in
Raritan, N.J.
William A McGann, M.D. ’77, directs the
San Francisco orthopaedic residency program and is chief of orthopaedics at St.
Mary’s Hospital and Medical Center. He
performs total joint replacements at San
Francisco Orthopaedic Medical Group.
Robert A. Stern, M.D. ’76, and wife Anita
are doing well in Poughkeepsie, N.Y.
Daughter Karyn is an endodontist in
Boston, and daughter Jodi is an attorney
in New York City; son Joshua is a fellow
in cardiology at NYU. “Hope all classmates are well!”
Biagio Mignone, M.D. ’75, announces
that son Paul Mignone, M.D. ’06, will be
starting his ophthalmology residency at
St. Luke’s/Roosevelt Hospital upon completion of his internship in Spokane,
Wash.
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Jack Albert, M.D. ’74, writes that daughter Amanda has graduated at age 17½
with honors in piano from Lynn University
in Boca Raton, Fla. Son Josh, 13, is in
eighth grade at Creekside Middle School
and made all-county and all-state percussion bands.
Steven Weinstock, M.D. ’74, reports that
this year he completed the Hermosa
Beach to Manhattan Beach, pier-to-pier,
two-mile rough water swim in 59 minutes,
“my best time in eight years.” Dr.
Weinstock says he is thinking about retiring and swimming full time, but has seven
grandchildren to help. He also has celebrated his 37th wedding anniversary with
Shelley.
Harvey Zara, M.D. ’73, writes that he and
wife Shelley retired and moved to Vermont
in 2005. “We work very hard at being ski
bums.”
Robert M. D’Alessandri, M.D. ’71, commonly known as “Dr. Bob” from his televised medical shows, is stepping down as
vice president for health sciences at West
Virginia University. A specialist in infectious diseases and general medicine, Dr.
D’Alessandri was dean of the WVU School
of Medicine from 1989 to 2004. He now
appears as a medical correspondent on
“Doctors on Call,” which appears on West
Virginia Public Television.
Thomas B. Graboys, M.D. ’70, has been
promoted to full professor at Harvard
Medical School and is awaiting April publication of his book, Life in The Balance, A
Physician’s Memoir of Life, Love and Loss
with Parkinson’s Disease and Dementia.

The Sixties
Richard Hirsh, M.D. ’69, continues his
international mammography teaching
projects, having completed three missions
to Nicaragua, Serbia, and Macedonia in
2007. Dr. Hirsh plans to travel to Kenya in
March 2008. In July 2007 he received the
Service Award from the Akron Peace
Council.
Richard Fogler, M.D. ’68, is chairman of
surgery and chief medical officer at
Brookdale University Hospital and Medical
Center in Brooklyn, N.Y. Dr. Fogler is also
the proud father of Dan Fogler, a Tony
award-winning Broadway and film star.
Stephanie Roze, M.D. ’68, is practicing
pediatrics in Brooklyn, N.Y.
Marc Lowen, M.D. ’67, is ob/gyn program
director at Sinai Hospital in Baltimore,
Md., and also has a private gynecology
practice. He is enjoying his 10 grandchildren and writes, “We saw Dr. Richard
Stone in Salt Lake City and he looks
terrific.”

Michael Brody, M.D. ’66, is still practicing and “trying to get it right.”
Tony Cohen, M.D. ’66, is retired from
medicine.
Craig Jurgensen, M.D. ’66, having celebrated his 40th year since graduating
from medical school, is retired.
Steven Weissberg, M.D. ’66, has “finally”
given up obstetrics. “It’s a new life being
able to sleep through the night,” he
writes. “Best wishes to all fellow classmates. Would love to hear from you.”
Richard Allen, M.D. ’65, an ob/gyn and
assistant dean for graduate medical education and an adjunct professor at
Oregon Health and Science University,
received the American Medical Association’s 2007 Distinguished Service Award.
Leonard B. Krich, M.D. ’65, announces
that he and wife Barbara welcomed their
fourth grandchild (first girl) into the family in July 2007. “Simone joined cousins
Benjamin, McKaden, and Seth to round
out our family to an even dozen!”
Richard P. Singer, M.D. ’65, is retired as
medical director of Alameda County’s
Behavioral Health Care Services and from
his private psychiatry practice. Dr. Singer
and wife Nancy are enjoying more time
with their grandchildren and many more
leisurely stays at their lake house in the
“gold country” of California.
Francis P. MacMillan Sr., M.D. ’64, is
semi-retired from gastroenterology, practicing 2½ days per week in Haverhill,
Mass. Dr. MacMillan will be joining his
son, Francis P. MacMillan Jr., M.D., in
his new gastroenterology practice.
Howard D. Harrison, M.D. ’61, has
served a year as chair of the senior
physician group of the AMA. Dr. Harrison
had a shoulder replacement in January
2007.
Robert D. Hirsch, M.D. ’61, has retired
after 41 years in private ob/gyn practice.
“I miss the patient contact and diagnostic
challenges but not the malpractice risks.”
Dr. Hirsch plans to travel and catch up on
theater and non-medical literature.
Buck J. Williams, M.D. ’60, writes from
Sun City, Ariz., “Retirement is great!”

The Fifties
Anthony J. Rella, M.D. ’59, is retired
from the practice of general and thoracic
surgery. “All three of our children are
attorneys!” Dr. Rella and wife Helena plan

to enjoy retirement at home in New York
or at their vacation home in Key Biscayne,
Fla.
Cecelia A. Young, M.D. ’59, is practicing
internal medicine part time in Stony
Brook but plans on retiring in the near
future. Dr. Young has spoken with many
classmates, including Helen Toomey,
M.D. ’59, who spends her time mostly
between New Hampshire and
Southampton, L.I., with trips to Maine to
see her two grandsons Mathew and
Jacob; Paul A Stavrolakes, M.D. ’59, who
has moved with wife Jean into a condo in
Port Jefferson, L.I.; Jane Engelke, widow
of Harold Engelke, M.D. ’59, who died
suddenly of cardiac arrest; John Starke,
M.D. ’59, who with his wife Jane sent a
2006 Christmas card from Little Silver,
N.J. with a picture of themselves with
their gorgeous new grandson; and,
Margarita R. DeSantis, M.D. ’59, who
retired from pediatric practice but is still
living in Orange, N.J.
Raymond Bagg, M.D. ’58, has completed
30 years with Texas Tech School of
Medicine, preceded by 20 years with the
U.S. Army Medical Department. “I am
approaching the level of grand master in
bureaucratic survivalship.”
Robert J. Blankfein, M.D. ’58, can’t wait
to attend the 50th class reunion in New
York City in May 2008.
Arthur Ginsburg, M.D. ’58, is retired and
eagerly anticipating the 50th reunion.
Owen E. Heninger, M.D. ’57, is practicing
psychiatry in Whittier, Calif.
Kenneth L. Becker, M.D. ’56, Ph.D., is
the 2007 recipient of the Endocrine
Society’s Distinguished Educator Award,
which recognizes exceptional achievement
as an educator in the discipline of
endocrinology and metabolism. Dr.
Becker, who is director of the endocrine
program at George Washington University
and chief of endocrinology at the
Washington Veterans Affairs Medical
Center, has spent the past two decades
studying neuroendocrine secretory products and has, with his associates, developed a new methodology for the therapy
of sepsis. He has written two textbooks,
Principles and Practice of Endocrinology
and Metabolism, and The Endocrine Lung
in Health and Disease.
Gabriel Gregoratos, M.D. ’54, is clinical
professor of medicine emeritus at the
University of California, San Francisco. Dr.
Gregoratos teaches and conducts consultation rounds part time. He was recently
honored with the 2007 Gifted Teacher
Award of The American College of
Cardiology.

ALUMNI
A Man of Many Coats
(continued from page 21)

In Memoriam

the bar on his first try and
joined his father, an immigration law expert, in a small,
two-room law office. He continued to practice anesthesia
full-time, with law on the side.
“I was earning my living as an
anesthesiologist and doing law
work primarily to spend some
time with my dad,” he said.
Even then, his professional
appetite was not sated.
During the mid 1990s, he
decided to train to become a
pro tempore justice of the
peace so he could substitute
for judges who were retiring,
on vacation or sick. His interest in the judiciary grew and,
when he wasn’t practicing
anesthesia, he began spending more time in the courtroom, watching and listening.
“I spent hundreds of hours at
no pay sitting and listening
and questioning—and I eventually became very qualified to
be a judge,” said Dr. Angiulo,

who retired from his part-time
law practice in 1997.
In 2000 Dr. Angiulo stopped
practicing anesthesiology full
time and accepted a two-year
appointment as judge in the
town of Sahuarita. Two years
later he was elected justice of
the peace for the precinct that
covers the area where he
lives. His fellow judges have
since elected him presiding
judge of all Pima County justice courts.
His job may seem far removed
from medicine or private practice law, but Dr. Angiulo still
gathers information to try to
solve problems, all with the
goal of helping others. And,
when he is not in court, he is
keeping his medical license
up to date, taking CMEs and
attending meetings. “The oil in
my lamp has never run dry,”
he likes to say. ⽧

Brooke L. Brennan, M.D. ’01, died
March 10, 2007 in Danville, Ky. She
was 34.
Lorena ‘Katie’ M. Leone, M.P.H. ’99,
died March 25, 2007 in Ridgefield Park,
N.J. She was 55.
Joseph J. Stavola, M.D. ’87, died June
9, 2007 in Westport, Conn. He was 46.
Robert B. Burdick, M.D. ’77, died May
2, 2007 in Wisconsin. He was 61.
James Joseph DeLigio, M.D. ’74, died
December 15, 2006.
Barbara E. Bess, M.D. ’65, died August
26, 1999 in New York, N.Y. She was 61.
John R. Morgan III, M.D. ’62, died
March 18, 2007 in Trenton, N.J.
Criss Kidder, M.D. ’61, died June 26,
2006 in Anahola, Hawaii. He was 72.
John Elkas, M.D. ’60, died April 10,
2007 in Caldwell, N.J. He was 73.
Norris K. Culf, M.D. ’57, died April 2,
2007 in Stuart, Fla. He was 75.
Charles J. Zmijeski, M.D. ’57, died
May 21, 2001. He was 70.
Harry Allen, M.D. ’56, died on June 4,
2006.
Thomas F. Fogarty, M.D. ’55, died July
26, 2007 in Pelham, N.Y.

Calendar of Events
January 27 – 30, 2008
25th Annual Alumni CME Winter Seminar
“Healthcare in the 21st Century”
LaQuinta Resort & Club
LaQuinta, CA
.....................................................
May 17, 2008
Annual Alumni Banquet and Awards Presentation
.....................................................
May 18, 2008
Five-Year Class Reunions Luncheon
.....................................................
May 21, 2008
149th Commencement
.....................................................
For more information, please contact
Alumni Relations at (914) 594-4556.

Eugene Greider, M.D. ’52, died April
16, 2007. He was 88.
Rita Girolamo, M.D. ’51, died on
September 8, 2007. She was 80.
Clemens E. Prokesch, M.D. ’49, died
May 1, 2007 in New London, Conn. He
was 88.
Bruce Jeffery Ebbels, M.D. ’48, died
March 22, 2007 in Watertown, N.Y. He
was 82.
Bela R. Rieger, M.D. ’47, died on May
3, 2007. He was 85.
Henry M. Kaplan, M.D. ’44, died on
October 10, 2007.

Clifford F. Moran, M.D. ’42, died
January 16, 2004. He was 88.
John J. Konefal, M.D. ’41, died April
29, 2007 in Charlotte, N.C. He was 90.
Joseph M. Wool, M.D. ’41, died
February 22, 2007. He was 93.
Vincent Lodico, M.D. ’40, died on
January 11, 2006.
Alfred L. Lewis, M.D. ’39, died August
5, 2006. He was 93.
George J. Mastellone, M.D. ’39, died
June 12, 2007 in Williamstown, Mass.
He was 93.
Joseph M. Teta, M.D. ’38, died May 20,
2007 in Vero Beach, Fla. He was 94.
Frank M. Galioto, M.D. ’34, died
December 1, 1996. He was 86.
George R. Nagamatsu, M.D. ’34, died
October 24, 2001. He was 98.

Faculty
Joseph A. Cimino, M.D., M.P.H., professor and chairman of the Department
of Community and Preventive Medicine,
died on July 1, 2007 at Calvary Hospital
in the Bronx, N.Y., from complications
of prostate cancer. He was 73.
Arthur L. DeAngelis, M.D., clinical
assistant professor of medicine until
1996, died August 25, 2007. He
was 63.
Rita Girolamo, M.D. ’51, professor
emeritus of radiology, died on
September 8, 2007. She was 80.
Edward Holtzman, M.D., assistant
clinical professor of psychiatry and
behavioral sciences, died June 25,
2007. He was 82.
Vincent J. Merendino, M.D. ’42,
professor of clinical obstetrics and
gynecology from 1954 to 1997,
died April 8, 2007 in Englewood, N.J.
He was 90.

John Wallace “Jack” Nevins, M.D. ’44,
died on August 24, 2007 in Palm
Springs, CA.
Margaret Harte-Madden, M.D.’43, died
on September 21, 2007.
James V. McNulty, M.D. ’43, died May
13, 2007 in La Jolla, Calif. He was 89.
Vincent J. Merendino, M.D. ’42, died
April 8, 2007 in Englewood, N.J. He
was 90.
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